Medical News Today -
9 Sep 2013 11:00
Sumagen Canada Inc and Western University has announced that the Phase I Clinical Trial (SAV CT 01) of the first and only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H) has been successfully completed with no adverse effects in all patients. Antibody production was also boosted after vaccination. Developed by Dr...
Share this Article